🎗️ Now Streaming: ReSPECT-GBM Patient Story – Jim’s Journey as a Recurrent Glioblastoma Survivor
Watch Jim’s Inspiring Story Now on YouTube: Watch Jim’s Story
Dr. Jim Stockand, a dedicated educator with a PhD in Physiology, has devoted the past 24 years to inspiring students in the academic realm. However, in 2022, his life took an unforeseen turn when he was diagnosed with glioblastoma, an aggressive form of brain cancer. Following standard of care treatment, Dr. Stockand encountered a setback when the glioblastoma recurred merely 9 months later. In January 2023, he decided to participate in the ReSPECT-GBM trial for recurrent glioblastoma. The day after receiving his single-dose treatment, Dr. Stockand explains how he and his wife were able to undertake a 7-mile walk together—an activity he had been unable to enjoy for nearly a year.
Dr. Stockand’s journey not only underscores the challenges faced by individuals battling this difficult cancer diagnosis but also illuminates the moments of joy that can arise amidst adversity.
For More Information About the ReSPECT-GBM Clinical Trial:
- Learn more about the ReSPECT-GBM trial for recurrent glioblastoma here: ReSPECT-GBM Clinical Trials
- Discover more about Plus Therapeutics and their innovative treatments: Plus Therapeutics
Why Watch This Patient Story?
This patient testimonial video is a testament to the resilience and hope that defines the glioblastoma community. By watching Dr. Stockand’s journey, you’ll gain insight into the realities of living with recurrent glioblastoma.
Don’t forget to subscribe to our YouTube channel for more inspiring stories, updates, and insights into the glioblastoma clinical trials landscape.
Recent Comments